Verzenio Effectiveness
Multiple studies have shown that Verzenia can be effective in treating metastatic or advanced breast cancer that is HER2-negative or HR-positive. Specifically, those people who took the medication with fulvestrant may go 16.5 months without any progression. For the objective response rate, which indicates the percentage of people who had partial or complete abscene of cancerous cells, the figure was more than 48 percent. When taken with an aromatase inhibitor, this number went up to 55.5 percent.[7]
